Krebs Biochemicals & IndustriesKREBSBIO 
$0.99-1.24%24h
-1.24%24h
Global rank29827
Market cap$21.32M
Change 7d-2.75%
YTD Performance7.37%
SP500 benchmarkUnderperform
P/E-0.09
P/S3.43
Revenue$6.21M
Earnings-$2.94M
Dividend yield-
Main Sector
Healthcare
Category
Krebs Biochemicals & Industries (KREBSBIO) Total Liabilities
KREBSBIO Total Liabilities in 2022: $32.70M
According to Krebs Biochemicals & Industries latest financial reports the total liabilities of KREBSBIO is $32.70M, an increase of 3.60% to 2022. At the end of 2022 company had $31.56M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Krebs Biochemicals & Industries is responsible for during its operational activities.
Krebs Biochemicals & Industries (KREBSBIO) Total Liabilities History from 2023 to 2022
-
Value:-
KREBSBIO Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $32.70M | 3.60% |
| 2022 | $31.56M | 31.17% |
| 2021 | $24.06M | 27.18% |
| 2020 | $18.92M | 26.90% |
| 2019 | $14.91M | - |
View the Top Total Liabilies Stocks
